NEW YORK (GenomeWeb) – Affymetrix said today that its board now plans to engage in discussions with Origin Technologies regarding its most recent proposal to acquire Affy for $17.00 per share in an all-cash transaction.

However, Affy's board of directors said it continues to recommend that its stockholders vote in favor of the adoption of a previously approved merger with Thermo Fisher Scientific, in which Thermo Fisher would acquire Affy for $14 per share, or approximately $1.3 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.